Tag: AC Immune
September 12, 2019
5 Alzheimer’s Disease Treatment Stocks on the NASDAQ
A report from Reports and Data suggests the overall Alzheimer's market will be worth US$12.43 billion by 2026. November 13, 2018
AC Immune Reports Third Quarter 2018 Financial Results and Corporate Update
AC Immune (NASDAQ:ACIU), a Swiss-based, clinical-stage biopharmaceutical company with a broad pipeline focused on neurodegenerative diseases, announced financial results for... April 5, 2018
AC Immune Announces the Selection of Tau Small Molecules for Clinical Development in Alzheimer’s disease
AC Immune (NASDAQ:ACIU), a Swiss-based, clinical stage biopharmaceutical company with a broad pipeline focused on neurodegenerative diseases, today announced that... March 20, 2018
AC Immune reports full-year 2017 financial results
AC Immune (NASDAQ: ACIU), a Swiss-based, clinical stage biopharmaceutical company with a broad pipeline focused on neurodegenerative diseases, today announced...
October 26, 2017
The State of Novel Alzheimer's Treatments
Alzheimer's already affects nearly five million Americans, with a growing population incoming, the need for an improved treatment is a... September 23, 2016
AC Immune Opens For Trading On NASDAQ
AC Immune, a Swiss-based, clinical stage biopharmaceutical company focused on neurodegenerative diseases, today announced that its common shares will open... September 22, 2016